(Q48673745)

14 February 2018

title

Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe nighttime hypoxia. (English)

1 reference

14 February 2018

main subject

hypoxia

0 references

patient

0 references

obstructive sleep apnea

1 reference

4

1 reference

14 February 2018

Friedrich Grimminger

5

1 reference

14 February 2018

author name string

Richard Schulz

1

1 reference

14 February 2018

Christoph Hummel

2

1 reference

14 February 2018

Sabine Heinemann

3

1 reference

14 February 2018

language of work or name

English

0 references

publication date

1 January 2002

1 reference

14 February 2018

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

14 February 2018

volume

165

1 reference

14 February 2018

issue

1

1 reference

14 February 2018

page(s)

67-70

1 reference

14 February 2018

Cardiovascular morbidity in obstructive sleep apnea

cites work

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.1.2101062

Prospective study of the association between sleep-disordered breathing and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.1.2101062

Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.1.2101062

Molecular and biological properties of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.1.2101062

The vascular endothelial growth factor family; proteins which guide the development of the vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.1.2101062

Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.1.2101062

Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.1.2101062

Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.1.2101062

Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.1.2101062

Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.1.2101062

Stimulatory interaction between vascular endothelial growth factor and endothelin-1 on each gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.1.2101062

Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.1.2101062

Carbon monoxide and nitric oxide suppress the hypoxic induction of vascular endothelial growth factor gene via the 5' enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.1.2101062

Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure. A preliminary investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.1.2101062

10.1164/AJRCCM.165.1.2101062

21 January 2018

Identifiers

DOI

1 reference

14 February 2018

1 reference

14 February 2018